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Themolecular epidemiology of 66 NDM-producing isolates from 2 Pakistani hospitals was investigated, with their genetic relat-
edness determined using repetitive sequence-based PCR (Rep-PCR). PCR-based replicon typing and screening for antibiotic re-
sistance genes encoding carbapenemases, other -lactamases, and 16S methylases were also performed. Rep-PCR suggested a
clonal spread of Enterobacter cloacae and Escherichia coli. A number of plasmid replicon types were identified, with the incom-
patibility A/C group (IncA/C) being the most common (78%). 16S methylase-encoding genes were coharbored in 81% of NDM-
producing Enterobacteriaceae.
With the worldwide spread of the NDM-1 gene and its vari-ants (NDM-2 to NDM-8) (1, 2), molecular epidemiological
studies of global isolates using various genotyping techniques are
essential for gaining a better understanding of how this spread is
occurring. India, Pakistan, and Bangladesh are clearly major res-
ervoir countries for blaNDM, with numerous factors, such as anti-
biotic selection pressure, contributing to this current situation (3,
4). This study examines a group of 66 NDM-1-producing isolates
from Pakistan for their genetic relatedness, phylotype, plasmid
replicon type, and plasmid transferability.
All isolates were acquired from stool samples from 37 distinct
patients at twomilitary hospitals in Rawalpindi, Pakistan (5). The
samples were collected from inpatients (35%) and outpatients
(65%). The isolates were tested for susceptibility to 17 antimicro-
bials using the Vitek 2 system. The MICs for meropenem, dorip-
enem, fosfomycin, and amdinocillin were determined using a
standard agar dilution methodology (5).
The isolates were reconfirmed for the presence of the carbap-
enem resistance gene blaNDM-1 by PCR, as previously described
(6). PCRwas also performed to detect blaOXA-48, blaOXA-23, blaVIM,
blaIMP, blaKPC, blaCTX-M-15, blaSHV, blaTEM, blaOXA-1 group, AmpC
-lactamases, blaCMY-2, and the 16S rRNAmethylase genes armA,
rmtB, rmtC, and rmtF (6–9). The phylogenetic groups of Esche-
richia coli were determined using a multiplex (PCR)-based
method (10).
Repetitive sequenced-based PCR (Rep-PCR)-based typing by
theDiversiLab system (bioMérieux, Oakleigh, Australia) was used
for assessing clonal relatedness. A cluster of closely related isolates
was defined as isolates sharing95% similarity and indistinguish-
able isolates of97% (11, 12). PCR-based replicon typing analy-
sis (PBRT) was performed to determine the plasmid incompati-
bility (Inc) groups for all Enterobacteriaceae isolates (13).
Ten genetically diverse E. coli isolates, based on different Rep-
PCR profiles and phylogroups, were selected for transformation
studies and typing by multilocus sequence typing (MLST). MLST
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TABLE 1 Resistance genes and plasmid replicon types of NDM-1-producing isolates
NDM-producing isolates
(no.)
No. (%) of antibiotic resistance genes
Plasmid replicon type(s) (no.)
-Lactamasesa 16S rRNA methylases
blaCMY-2 blaCTX-M-15 blaSHV blaTEM blaOXA-1 rmtB rmtC rmtF armA
Escherichia coli (30) 26 (87) 16 (53) 0, 19 (63) 9 (30) 8 (27) 20 (67) 0 15 (50) IncHI1 (10), IncI1 (2), IncL/M (2),
IncN (4), IncFIA (5), IncFIB (6),
IncY (2), IncA/C (25), IncFII (9)
Enterobacter cloacae (21) 16 (76) 21 (100) 0, 20 (95) 20 (95) 0 15 (71) 0 14 (67) IncA/C (19), untypeable (2)
Citrobacter freundii (4) 3 (75) 2 (50) 0, 2 (50) 2 (50) 0 0 0 1 (14) IncA/C (2), IncFII (1), untypeable (1)
Acinetobacter baumannii (3) 0 0 0 0 0 0 0 0 NDb
Klebsiella pneumoniae (3) 1 (33) 3 (100) 3 (100), 3 (100) 3 (100) 1 (33) 0 1 (33) IncN (1), IncA/C (1), untypeable (1)
Pseudocitrobacter faecalis (2) 0 2 (100) 0, 2 (100) 2 (100) 0 0 0 0 IncN (2)
Providencia rettgeri (2) 2 (100) 0 0, 0 1 (50) 0 1 (50) 0 2 (100) IncA/C (1), IncN (2), IncY (1)
Citrobacter braakii (1) 1 (100) 0 0, 0 0 0 1 (100) 0 0 IncA/C (1)
Total no. of isolatesc 49 (78) 44 (70) 3 (5), 46 (73) 37 (59) 8 (13) 38 (60) 0 33 (52) IncA/C (49)
a All isolates were negative for blaOXA-48, blaIMP, blaVIM, and blaKPC.
b ND, not determined.
c A. baumannii excluded from this total.
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included seven conserved housekeeping genes and was performed
according to the E. coli MLST Database (see http://mlst.warwick
.ac.uk/mlst/dbs/Ecoli).
The transferability of blaNDM-1-carrying plasmids was investi-
gated by electroporation. PlasmidDNAwas prepared and electro-
porated into the recipient TOP10 E. coli (Invitrogen, Melbourne,
Victoria, Australia), as previously described (6). Successful elec-
trotransformants carrying blaNDM-1 were confirmed by PCR. The
plasmid replicon type of the transformants acquiring blaNDM-1-
carrying plasmids was confirmed by PBRT. Plasmid size was de-
termined by performing S1 endonuclease (Promega; Madison,
WI, USA) restriction digestion using pulsed-field gel electropho-
resis (PFGE) (14). PCR-amplified DNA probes of blaNDM-1 were
labeled with digoxigenin nucleic acid (Roche, Mannheim, Ger-
many).
Widespread dissemination of NDM-1 in Pakistan was first de-
scribed in 2010 (15). In this study, we investigated the molecular
epidemiology of a group of NDM-1-producing isolates from Pak-
istan, andwe report here on the clonal relatedness of these isolates,
providing an insight into the molecular characterization of
blaNDM-1-carrying plasmids.
Themajority of the NDM-1-producing Enterobacteriaceae iso-
lates coharbored an extended-spectrum-lactamase (ESBL) gene,
FIG1 Southernblothybridizationof thePFGEgelwitha specificblaNDM-1probe.
The black arrows indicate positive signals with the NDM-1 probe in each E. coli
clinical isolate and its corresponding transformant. Lanes 1 to 8, PN1, PN1
TF1, PN7, PN7 TF1, PN14, PN14 TF1, PN18, and PN18 TF1, respectively.
FIG 2 Dendrogram analysis of DiversiLab Rep-PCR fingerprint of NDM-1-producing E. cloacae isolates.
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blaCTX-M-15 (70%). blaCMY-2 and the cooccurrence of 16S rRNA
methylase genes encoding broad-spectrum aminoglycoside resis-
tance, rmtB, rmtC, or armA, was detected in 47 (75%) isolates
(Table 1). AmpC-lactamase production coexistingwith anESBL
was also high (n  36 [73%]). The novel 16S rRNA methylase
rmtF (16) was not detected; however, rmtB was found in 8 E. coli
strains. A strong association between NDM-producing isolates
harboring a 16S rRNA methylase-encoding gene has been well
documented, particularly with rmtC.More recent studies in India,
the United Kingdom, South Africa, and Nepal have reported the
carriage of rmtF amongNDM-harboring isolates (9, 17–19). rmtB
together with blaNDM is a rare association, although a recent out-
break of E. coli isolates in Bulgaria, harboring both blaNDM-1 and
rmtB genes, raises new concerns for the acquisition of resistance
determinants (20). Our results suggest that NDM-1-producing
Enterobacteriaceae from Rawalpindi, Pakistan, have acquired a
broad spectrum of singular and distinct resistance genes.
The plasmid incompatibility typesHI1, I1, L/M,N, FIA, FIB, Y,
A/C, and FII were identified among the NDM-1-producing iso-
lates (Table 1). Plasmid replicon typing revealed the dominance of
two incompatibility groups, IncA/C (78%) and IncF (33%), with
IncA/C occurring in multiple NDM-carrying species. IncA/C
plasmids carrying blaNDM have been reported in Pakistan (21).
Of the 10 E. coli isolates subjected to electroporation, the
blaNDM-1 plasmids in 4 isolates were successfully electroporated.
Plasmid replicon typing of these transformants confirmed that
blaNDM-1 resides on IncA/C-, IncN-, IncFIB-, and IncFII-type
plasmids. These replicon types have been reported in Enterobac-
teriaceae in many regions of the world (4).
Southern hybridization (Fig. 1) of the E. coli donors and their
transformants revealed blaNDM-1 plasmid sizes ranging from50
kb to350 kb. The majority of the blaNDM-1 plasmids were140
kb in size. Among the 30 E. coli isolates, there was a predominance
of the phylogenetic group B1 (57%), followed by phylotypes A
(40%) andD (3%). It has been suggested that the distribution ofE.
coli phylotypesmay be geographically dependent (22).Mushtaq et
al. (23) found a prevalence of phylotype B1 among NDM isolates
in Pakistan and no phylotype B2. Our study shows similar results.
Rep-PCR revealed two dominant clones among Enterobacter
cloacae, one large cluster (n 17), designated ECLI, and one small
cluster of three isolates (ECLII) (see Fig. 2). Three clonal types
were observed among 17 E. coli isolates, and the remaining E. coli
FIG 3 Dendrogram analysis of DiversiLab Rep-PCR fingerprint of NDM-1-producing E. coli isolates by phylotype.
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isolates were diverse (Fig. 3). The three Klebsiella pneumoniae iso-
lates were genetically diverse, while the three Acinetobacter bau-
mannii isolates were considered identical (99% similarity) (data
not shown). Figure 4 shows the dendrogram for Citrobacter spp.
and Pseudocitrobacter faecalis isolates (99% similarity).
MLST differentiated the 10 representative E. coli strains into
seven sequence types and one unknown sequence type (ST) (un-
typeable). The sequence types included ST10 (n 2), ST101 (n
2), and single isolates representing STs 211, 226, 1431, 2598, and
3032. MLST studies on NDM-1-producing E. coli in the literature
provide an incomplete and heterogeneous global distribution,
suggesting a nonclonal pattern of spread for blaNDM-1 (24). In this
study, the clinical isolates of E. coli representing STs 211, 226,
1431, 2598, and 3032 to our knowledge have not been reported in
NDM-1-producing E. coli.
There were a number of limitations in our study, including the
lack of clinical patient data and using fecal samples from 2 hospi-
tals at a single point in time. It is difficult in this respect to obtain
a clear epidemiological picture of NDM-producing isolates more
widely in Pakistan.
The spread of blaNDM-1 is frequently associated with common
and highly promiscuous plasmids resulting in a diverse range of
species and clones harboring blaNDM-1. However, the molecular
epidemiology of our studymay indicate that blaNDM-1 additionally
disseminates via dominant clones. The potential role of such
dominant clones as a factor of blaNDM-1 spread may be underrep-
resented due to the lack of large-scale surveillance and molecular
epidemiological studies monitoring blaNDM-1 dissemination. In
this scenario, we can see a situation in which a single clone of
NDM-1 may become epidemic or pandemic.
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